NO20005724L - Biologisk aktiv sammensetning - Google Patents
Biologisk aktiv sammensetningInfo
- Publication number
- NO20005724L NO20005724L NO20005724A NO20005724A NO20005724L NO 20005724 L NO20005724 L NO 20005724L NO 20005724 A NO20005724 A NO 20005724A NO 20005724 A NO20005724 A NO 20005724A NO 20005724 L NO20005724 L NO 20005724L
- Authority
- NO
- Norway
- Prior art keywords
- biologically active
- active agent
- carrier
- active composition
- chemical reaction
- Prior art date
Links
- 239000013543 active substance Substances 0.000 abstract 4
- 238000006243 chemical reaction Methods 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 229920000728 polyester Polymers 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9801704A SE9801704D0 (sv) | 1998-05-14 | 1998-05-14 | Biologically active composition |
| PCT/SE1999/000823 WO1999058108A1 (fr) | 1998-05-14 | 1999-05-12 | Composition biologiquement active |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005724D0 NO20005724D0 (no) | 2000-11-13 |
| NO20005724L true NO20005724L (no) | 2001-01-09 |
Family
ID=20411318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005724A NO20005724L (no) | 1998-05-14 | 2000-11-13 | Biologisk aktiv sammensetning |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6537576B1 (fr) |
| EP (1) | EP1082102B1 (fr) |
| JP (1) | JP2002514587A (fr) |
| KR (1) | KR100592971B1 (fr) |
| CN (1) | CN1309553A (fr) |
| AT (1) | ATE310500T1 (fr) |
| AU (1) | AU736480B2 (fr) |
| CA (1) | CA2331527C (fr) |
| DE (2) | DE69928524T2 (fr) |
| ES (1) | ES2155048T3 (fr) |
| GR (1) | GR20010300013T1 (fr) |
| HU (1) | HUP0102426A2 (fr) |
| IL (2) | IL139576A0 (fr) |
| NO (1) | NO20005724L (fr) |
| NZ (1) | NZ508073A (fr) |
| PL (1) | PL344051A1 (fr) |
| SE (1) | SE9801704D0 (fr) |
| TR (1) | TR200003589T2 (fr) |
| WO (1) | WO1999058108A1 (fr) |
| ZA (1) | ZA200006474B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001064149A1 (fr) * | 2000-02-29 | 2001-09-07 | Jie Zhang | Timbre transdermique pour medicament ameliore |
| AU2007260739A1 (en) | 2006-06-14 | 2007-12-21 | Dr. Reddy's Laboratories Limited | Topical compositions |
| US20080226698A1 (en) * | 2007-03-16 | 2008-09-18 | Mylan Technologies, Inc. | Amorphous drug transdermal systems, manufacturing methods, and stabilization |
| AU2009302853B2 (en) | 2008-10-06 | 2014-09-11 | Mylan Technologies, Inc. | Amorphous rotigotine transdermal system |
| JP6114841B2 (ja) | 2013-02-28 | 2017-04-12 | ダーミラ， インク．Ｄｅｒｍｉｒａ， Ｉｎｃ． | グリコピロレート塩 |
| US8558008B2 (en) | 2013-02-28 | 2013-10-15 | Dermira, Inc. | Crystalline glycopyrrolate tosylate |
| US9006462B2 (en) | 2013-02-28 | 2015-04-14 | Dermira, Inc. | Glycopyrrolate salts |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD217989A1 (de) | 1983-08-09 | 1985-01-30 | Univ Ernst Moritz Arndt | Verfahren zur herstellung einer pharmazeutischen zubereitung |
| US4940701A (en) * | 1984-01-25 | 1990-07-10 | Beecham Group P.L.C. | Topical drug release system |
| AR246186A1 (es) | 1989-11-17 | 1994-07-29 | Beta Pharm Co | Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica. |
| SE9502244D0 (sv) * | 1995-06-20 | 1995-06-20 | Bioglan Ab | A composition and a process for the preparation thereof |
| US5906830A (en) * | 1995-09-08 | 1999-05-25 | Cygnus, Inc. | Supersaturated transdermal drug delivery systems, and methods for manufacturing the same |
| GB2306885B (en) * | 1995-11-08 | 1999-07-14 | Reckitt & Colmann Prod Ltd | Supersaturated Pharmaceutical Compositions |
-
1998
- 1998-05-14 SE SE9801704A patent/SE9801704D0/xx unknown
-
1999
- 1999-05-12 CN CN99808547A patent/CN1309553A/zh active Pending
- 1999-05-12 DE DE69928524T patent/DE69928524T2/de not_active Expired - Lifetime
- 1999-05-12 EP EP99927061A patent/EP1082102B1/fr not_active Expired - Lifetime
- 1999-05-12 JP JP2000547960A patent/JP2002514587A/ja active Pending
- 1999-05-12 HU HU0102426A patent/HUP0102426A2/hu unknown
- 1999-05-12 CA CA2331527A patent/CA2331527C/fr not_active Expired - Fee Related
- 1999-05-12 PL PL99344051A patent/PL344051A1/xx unknown
- 1999-05-12 ES ES99927061T patent/ES2155048T3/es not_active Expired - Lifetime
- 1999-05-12 AU AU44050/99A patent/AU736480B2/en not_active Ceased
- 1999-05-12 IL IL13957699A patent/IL139576A0/xx active IP Right Grant
- 1999-05-12 WO PCT/SE1999/000823 patent/WO1999058108A1/fr active IP Right Grant
- 1999-05-12 KR KR1020007012708A patent/KR100592971B1/ko not_active IP Right Cessation
- 1999-05-12 NZ NZ508073A patent/NZ508073A/xx not_active IP Right Cessation
- 1999-05-12 AT AT99927061T patent/ATE310500T1/de not_active IP Right Cessation
- 1999-05-12 TR TR2000/03589T patent/TR200003589T2/xx unknown
- 1999-05-12 DE DE1082102T patent/DE1082102T1/de active Pending
- 1999-05-12 US US09/700,176 patent/US6537576B1/en not_active Expired - Lifetime
-
2000
- 2000-11-09 IL IL139576A patent/IL139576A/en not_active IP Right Cessation
- 2000-11-09 ZA ZA200006474A patent/ZA200006474B/xx unknown
- 2000-11-13 NO NO20005724A patent/NO20005724L/no not_active Application Discontinuation
-
2001
- 2001-04-30 GR GR20010300013T patent/GR20010300013T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL139576A (en) | 2007-07-04 |
| HUP0102426A2 (hu) | 2002-03-28 |
| ATE310500T1 (de) | 2005-12-15 |
| CN1309553A (zh) | 2001-08-22 |
| SE9801704D0 (sv) | 1998-05-14 |
| NZ508073A (en) | 2002-12-20 |
| WO1999058108A1 (fr) | 1999-11-18 |
| DE69928524D1 (de) | 2005-12-29 |
| TR200003589T2 (tr) | 2001-03-21 |
| EP1082102B1 (fr) | 2005-11-23 |
| KR100592971B1 (ko) | 2006-06-23 |
| NO20005724D0 (no) | 2000-11-13 |
| CA2331527A1 (fr) | 1999-11-18 |
| JP2002514587A (ja) | 2002-05-21 |
| ES2155048T3 (es) | 2006-06-16 |
| GR20010300013T1 (en) | 2001-04-30 |
| DE69928524T2 (de) | 2006-08-10 |
| ES2155048T1 (es) | 2001-05-01 |
| IL139576A0 (en) | 2002-02-10 |
| DE1082102T1 (de) | 2001-09-06 |
| PL344051A1 (en) | 2001-09-24 |
| EP1082102A1 (fr) | 2001-03-14 |
| KR20010052348A (ko) | 2001-06-25 |
| CA2331527C (fr) | 2010-04-13 |
| US6537576B1 (en) | 2003-03-25 |
| AU4405099A (en) | 1999-11-29 |
| ZA200006474B (en) | 2001-09-04 |
| AU736480B2 (en) | 2001-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pommier et al. | The formation and resealing of intercalator-induced DNA strand breaks in isolated L1210 cell nuclei | |
| AR030043A1 (es) | Sistema de agentes de hidrofobizado, polisiloxano, procedimiento para la obtencion de polisiloxanos, dispersiones acuosas, procedimiento para la obtencion de dispersiones acuosas, procedimiento para el hidrofobizado de sustratos, sustratos hidrofobizados y empleo del sistema de agentes de hidrofobiz | |
| KR910009849A (ko) | 기질 처리방법 | |
| NO20005724L (no) | Biologisk aktiv sammensetning | |
| Patil et al. | Sucrose diacrylate: a unique chemically and biologically degradable crosslinker for polymeric hydrogels | |
| TR200200822T2 (tr) | Uçucu bileşiklerin sıvı solüsyon içindeki katı maddelerden çıkarılması süreci | |
| KR910006155A (ko) | 유출액이 함유하는 유기물질 및 설페이트를 제거하기 위해 혐기성 발효를 이용하여 유출액을 처리하는 방법 | |
| BR0109265A (pt) | Processo para a obtenção de polihidroxialcanoatos (pha) ou seus copolìmeros e utilização de agentes de redução | |
| NO980861L (no) | Granulat med risleevne og basert på organiske syrer, fremgangsmåte for fremstilling, samt anvendelse | |
| CA2048242A1 (fr) | Les 4-amino-4-steroides et leur utilisation comme inhibiteurs de la 5.alpha.-reductase | |
| Guillory et al. | Covalent labeling of the tetrodotoxin receptor in excitable membranes | |
| BRPI0514743A (pt) | métodos de isolamento de 1, 3-propanodiol e de 1, 2-propanodiol | |
| EP0331745A4 (en) | Ferrocene derivatives, surfactants containing same, and process for producing thin organic film | |
| NO20005725D0 (no) | Biologisk aktiv sammensetning | |
| DE19634122A1 (de) | Neuartige Bäder zur Erzeugung von Mikrostrukturen | |
| Quastel | The mechanism of bacterial action | |
| TW200506531A (en) | Photoresist composition for deep uv and process thereof | |
| BR9807726A (pt) | Processo para a preparação de um composto | |
| JPS60243165A (ja) | 一時的保護被膜及びその製造方法 | |
| CA2353529A1 (fr) | Procede de reduction des lesions provoquees par les radicaux libres | |
| DE69928254D1 (de) | Behandlung von zellen | |
| BR0005589A (pt) | Processo de reciclo de catalisadores homogêneos em sistemas lìquidos bifásicos contendo polìmero e solventes orgânicos | |
| DE3427888A1 (de) | Verfahren zur immobilisierung von biologischem material | |
| GB2404441A (en) | Assay methods relating to the action of geminin in the licensing of dna replication complexes in transformed cells | |
| KR910014148A (ko) | 흡수 침강형 정수제의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |